Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Dysfunction in Late-Life Depression
NCT04469959Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa in major depressive disorder (MDD), sponsored by Vanderbilt University Medical Center. Started Feb 2021; status: completed.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04469959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469959.